BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19207019)

  • 1. Family-based genome-wide association studies.
    Benyamin B; Visscher PM; McRae AF
    Pharmacogenomics; 2009 Feb; 10(2):181-90. PubMed ID: 19207019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designs for linkage analysis and association studies of complex diseases.
    Cui Y; Li G; Li S; Wu R
    Methods Mol Biol; 2010; 620():219-42. PubMed ID: 20652506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-stage testing strategies for genome-wide association studies in family-based designs.
    Murphy A; T Weiss S; Lange C
    Methods Mol Biol; 2010; 620():485-96. PubMed ID: 20652517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on genome-wide multi-stage family-based association studies.
    Van Steen K
    Stat Med; 2011 Aug; 30(18):2201-21. PubMed ID: 21590702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using genome-wide pathway analysis to unravel the etiology of complex diseases.
    Elbers CC; van Eijk KR; Franke L; Mulder F; van der Schouw YT; Wijmenga C; Onland-Moret NC
    Genet Epidemiol; 2009 Jul; 33(5):419-31. PubMed ID: 19235186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association studies of quantitative traits with related individuals: little (power) lost but much to be gained.
    Visscher PM; Andrew T; Nyholt DR
    Eur J Hum Genet; 2008 Mar; 16(3):387-90. PubMed ID: 18183040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family-based designs in the age of large-scale gene-association studies.
    Laird NM; Lange C
    Nat Rev Genet; 2006 May; 7(5):385-94. PubMed ID: 16619052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based family study designs: an interdisciplinary research framework for genetic epidemiology.
    Zhao LP; Hsu L; Davidov O; Potter J; Elston RC; Prentice RL
    Genet Epidemiol; 1997; 14(4):365-88. PubMed ID: 9271710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes.
    Handyside AH; Harton GL; Mariani B; Thornhill AR; Affara N; Shaw MA; Griffin DK
    J Med Genet; 2010 Oct; 47(10):651-8. PubMed ID: 19858130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAPL: a novel association test using case-control and family data and accounting for population stratification.
    Chung RH; Schmidt MA; Morris RW; Martin ER
    Genet Epidemiol; 2010 Nov; 34(7):747-55. PubMed ID: 20878716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics and human disease.
    Jiang YH; Bressler J; Beaudet AL
    Annu Rev Genomics Hum Genet; 2004; 5():479-510. PubMed ID: 15485357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of statistical methodologies for the detection of parent-of-origin effects in family trio genome-wide association data with binary disease traits.
    Connolly S; Heron EA
    Brief Bioinform; 2015 May; 16(3):429-48. PubMed ID: 24903222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma genetics and genomics 2009.
    Weiss ST; Raby BA; Rogers A
    Curr Opin Genet Dev; 2009 Jun; 19(3):279-82. PubMed ID: 19481925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association studies (GWAS) in complex diseases: advantages and limitations.
    Riancho JA
    Reumatol Clin; 2012; 8(2):56-7. PubMed ID: 22089059
    [No Abstract]   [Full Text] [Related]  

  • 15. The identification of colon cancer susceptibility genes by using genome-wide scans.
    Daley D
    Methods Mol Biol; 2010; 653():3-21. PubMed ID: 20721734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The search for complex disease genes: fault by linkage or fault by association?
    Baron M
    Mol Psychiatry; 2001 Mar; 6(2):143-9. PubMed ID: 11317215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree.
    Lesch KP; Selch S; Renner TJ; Jacob C; Nguyen TT; Hahn T; Romanos M; Walitza S; Shoichet S; Dempfle A; Heine M; Boreatti-Hümmer A; Romanos J; Gross-Lesch S; Zerlaut H; Wultsch T; Heinzel S; Fassnacht M; Fallgatter A; Allolio B; Schäfer H; Warnke A; Reif A; Ropers HH; Ullmann R
    Mol Psychiatry; 2011 May; 16(5):491-503. PubMed ID: 20308990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How next-generation sequencing is transforming complex disease genetics.
    Kilpinen H; Barrett JC
    Trends Genet; 2013 Jan; 29(1):23-30. PubMed ID: 23103023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linkage analysis and predicting genetic disease.
    Boughman JA; Stick MJ; Peterson DA; Cohen MM
    Clin Lab Med; 1992 Sep; 12(3):449-61. PubMed ID: 1521423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An extension of affected-pedigree-member analyses to triads of relatives.
    Grigorenko EL; Chang JT
    Genet Epidemiol; 1997; 14(6):1005-10. PubMed ID: 9433615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.